Table 4.

Linear associations between psoas muscle parameters and mortality in a meta-analysis of three independent patient populations in women.

	Hazard Ratio for Long-term Mortality
	Fixed effects	Sig.	Random effects	Sig.	I2
L3 Level measurement
PMA	0.934(0.820–1.065)	0.307	0.940(0.804–1.099)	0.438	0.17
PMD	0.949(0.843–1.068)	0.382	0.949(0.843–1.068)	0.382	0
PMA/height	0.936(0.820–1.067)	0.321	0.936(0.820–1.067)	0.321	0
PMA/BSA	1.001(0.881–1.137)	0.987	1.004(0.875–1.153)	0.949	0
sLPMA	0.914(0.806–1.037)	0.164	0.914(0.806–1.037)	0.164	0
pLPMA	0.944(0.829–1.075)	0.384	0.944(0.829–1.075)	0.384	0
L4 level measurement
PMA	0.888(0.778–1.012)	0.075	0.918(0.775–1.116)	0.391	0.28
PMD	0.935(0.835–1.046)	0.242	0.934(0.831–1.048)	0.3245	0
PMA/height	0.887(0.778–1.012)	0.075	0.908(0.762–1.081)	0.278	0.09
PMA/BSA	0.957(0.841–1.090)	0.512	0.999(0.818–1.219)	0.989	0.35
sLPMA	0.883(0.781–0.998)	0.047	0.883(0.781–0.998)	0.047	0
pLPMA	0.904(0.789–1.025)	0.115	0.904(0.789–1.025)	0.115	0

Abbreviations: PMA: Psoas muscle area; PMD: Psoas muscle density; BSA: body-surface area; sLPMA: sum score of lean psoas muscle mass; pLPMA: product score of lean Psoas.